Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Smiths Detection Educates First Responders on Technology to Protect against the Dangers of Fentanyl Exposure

Smiths Detection Inc.
Posted on: 01 Nov 17

Smiths Detection Inc. (SDI) is pioneering a series of educational workshops to inform first responders on how to use technology to protect themselves against fentanyl exposure. The series of workshops will explore scenarios where responders can utilize field-based detection and identification systems to mitigate the threat of exposure to the potentially lethal opioid.

“Sharing our expertise with first responders about how technology can be used to help reduce the risk of fentanyl exposure is critical in the face of this growing epidemic,” said Stephen Esposito, VP of Business Development and Sales at SDI. “Smiths Detection remains committed to using leading-edge technology to help ensure the safety and security of emergency responders and the communities that they protect.”

SDI offers a range of products capable of detecting and/or identifying fentanyl, and several of its analogues. These include:

  • HazMatID Elite, an infrared handheld chemical identifier which performs chemical analysis on solids and liquids;
  • ACE-ID, which utilizes laser Raman spectroscopy to test unknown substances without contact, including through clear plastic and glass containers; and
  • IONSCAN 600, a portable system that detects and identifies trace amounts of suspected narcotics in seconds.

SDI also provides ReachBackID, a 24/7/365 hotline, which gives first responders access to Ph.D. scientists to support the field-based analysis of a range of chemicals including fentanyl and several of its analogues.

SDI has recently held mission-based workshops in Dallas, TX, Baltimore, MD, Suffolk County, NY, and Gainesville, FL with more workshops planned in communities across the country.

Smiths Detection, part of Smiths Group, is a global leader in threat detection and screening technologies for military, air transportation, homeland security and emergency response markets. Our experience and history across more than 40 years at the frontline, enables us to provide unrivalled levels of expertise to detect and identify constantly changing chemical, biological, radiological, nuclear and explosive threats, as well as weapons, contraband and narcotics.

Our goal is simple – to provide security, peace of mind and freedom of movement upon which the world depends. For more information visit www.smithsdetection.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20171101006216/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.